JohnellOKanisJA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int2006; 17: 1726–1733.
3.
GriffinXLParsonsNAchtenJet al.Recovery of health-related quality of life in a United Kingdom hip fracture population: the Warwick Hip Trauma Evaluation – a prospective cohort study. Bone Joint J2015; 97-B: 372–382.
4.
HernlundESvedbomAIvergårdMet al.Osteoporosis in the European Union: medical management, epidemiology and economic burden. Arch Osteoporos2016; 8: 136–136.
5.
Court-BrownCMDuckworthADClementNDet al.Fractures in older adults. A view of the future?Injury2018; 49: 2161–2166.
6.
LemsWFRatermanHG. Critical issues and current challenges in osteoporosis and fracture prevention. An overview of unmet needs. Ther Adv Musculoskelet Dis2017; 9: 299–316.
7.
FernandezMAArnelLGouldJet al.Research priorities in fragility fractures of the lower limb and pelvis: a UK priority setting partnership with the James Lind Alliance. BMJ Open2018; 8: e023301–e023301.
GordonCMZemelBSWrenTALet al.The determinants of peak bone mass. J Pediatr2017; 180: 261–269.
10.
HarveyNCWMcCloskeyEVMitchellPJet al.Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures. Osteoporos Int2017; 28: 1507–1529.
11.
The National Hip Fracture Database, www.nhfd.co.uk (2015, accessed 22 April 2019).
12.
DreinhöferKEMitchellPJBéguéTet al.A global call to action to improve the care of people with fragility fractures. Injury2018; 49: 1393–1397.